Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Zwierzina, H.
80  Ergebnisse:
Personensuche X
?
1

Innovation in oncology clinical trial design:

Verweij, J. ; Hendriks, H.R. ; Zwierzina, H....
Cancer Treatment Reviews.  74 (2019)  - p. 15-20 , 2019
Link: https://doi.org/10.1016/..
 
?
2

Establishing of a primary cancer microtissue model to inves..:

Koeck, S. ; Zwierzina, M. ; Gamerith, G....
European Journal of Cancer.  110 (2019)  - p. S10 , 2019
Link: https://doi.org/10.1016/..
 
?
3

Soluble immune checkpoints CD27, Lag3, PD-L2 and Tim3 in ea..:

Gamerith, G. ; Hackl, H. ; Wallinger, P....
European Journal of Cancer.  92 (2018)  - p. S12 , 2018
Link: https://doi.org/10.1016/..
 
?
4

The influence of stromal cells on CD3+ CD8+ tumor infiltrat..:

Koeck, S. ; Zwierzina, M. ; Gamerith, G....
European Journal of Cancer.  92 (2018)  - p. S12 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Access to innovative oncology medicines in Europe:

Bergmann, L. ; Enzmann, H. ; Thirstrup, S....
Annals of Oncology.  27 (2016)  2 - p. 353-356 , 2016
Link: https://doi.org/10.1093/..
 
?
6

Serum CD44 levels predict survival in patients with low-ris..:

Loeffler-Ragg, J. ; Germing, U. ; Sperr, W.R....
Critical Reviews in Oncology/Hematology.  78 (2011)  2 - p. 150-161 , 2011
Link: https://doi.org/10.1016/..
 
?
7

Improving the efficacy of cancer immunotherapy:

Copier, J. ; Dalgleish, A.G. ; Britten, C.M....
European Journal of Cancer.  45 (2009)  8 - p. 1424-1431 , 2009
Link: https://doi.org/10.1016/..
 
?
8

P022 Serum CD44 levels predict survival in patients with lo..:

Stauder, R. ; Germing, U. ; Sperr, W....
Leukemia Research.  33 (2009)  - p. S71 , 2009
Link: https://doi.org/10.1016/..
 
?
9

P68 Proteomic changes in colorectal cancer cell lines in re..:

Auer, T. ; Gamerith, G. ; Sarg, B....
European Journal of Cancer Supplements.  7 (2009)  4 - p. 34 , 2009
Link: https://doi.org/10.1016/..
 
?
10

Consensus on the medical treatment of colon cancer:

Kornek, G. ; Scheithauer, W. ; Anghel, R....
memo - Magazine of European Medical Oncology.  1 (2008)  2 - p. 79-90 , 2008
Link: https://doi.org/10.1007/..
 
?
11

Adjuvant therapy of stage II colorectal cancer – who will b..:

Zwierzina, H.
memo - Magazine of European Medical Oncology.  1 (2008)  2 - p. 75-77 , 2008
Link: https://doi.org/10.1007/..
 
?
12

Proteomics, a new tool to monitor cancer therapy?:

Loeffler-Ragg, J. ; Sarg, B. ; Mueller, D....
memo - Magazine of European Medical Oncology.  1 (2008)  3 - p. 129-136 , 2008
Link: https://doi.org/10.1007/..
 
?
13

Clinical trial design issues: Session 2:

Chen, H.X. ; Tinetti, A. ; Zwierzina, H.
European Journal of Cancer Supplements.  5 (2007)  9 - p. 1 , 2007
Link: https://doi.org/10.1016/..
 
?
14

506 POSTER Cetuximab-induced thymidylate synthase inhibitio..:

Skvortsov, S. ; Skvortsova, I. ; Sarg, B....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 91 , 2007
Link: https://doi.org/10.1016/..
 
?
15

Pharmacoeconomics behind next-generation oncology drug deve..:

Zwierzina, H. ; Liliemark, J. ; deBock, A.
European Journal of Cancer Supplements.  5 (2007)  9 - p. 2 , 2007
Link: https://doi.org/10.1016/..
 
1-15